000			01911 a2200565 4500
005			20250516163442.0
264		0	_c20140522
008			201405s 0 0 eng d
022			_a1399-0012
024	7		_a10.1111/ctr.12201 _2doi
040			_aNLM _beng _cNLM
100	1		_aHeilman, Raymond L
245	0	0	_aDelayed allograft inflammation following alemtuzumab induction for kidney transplantation. _h[electronic resource]
260			_bClinical transplantation _c
300			_a772-80 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlemtuzumab
650	0	4	_aAllografts
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntilymphocyte Serum _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCase-Control Studies
650	0	4	_aDelayed Graft Function _xdiagnosis
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGlomerular Filtration Rate
650	0	4	_aGraft Rejection _xdiagnosis
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInflammation _xdiagnosis
650	0	4	_aKidney Failure, Chronic _xcomplications
650	0	4	_aKidney Function Tests
650	0	4	_aKidney Transplantation _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMycophenolic Acid _xanalogs & derivatives
650	0	4	_aPrognosis
650	0	4	_aRisk Factors
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aTacrolimus _xtherapeutic use
700	1		_aKhamash, Hasan A
700	1		_aSmith, Maxwell L
700	1		_aChakkera, Harini A
700	1		_aMoss, Adyr A
700	1		_aReddy, Kunam S
773	0		_tClinical transplantation _gvol. 27 _gno. 5 _gp. 772-80
856	4	0	_uhttps://doi.org/10.1111/ctr.12201 _zAvailable from publisher's website
999			_c22984028 _d22984028